These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 22828011)

  • 1. The impact of data transformations on concentration-response modeling.
    Weimer M; Jiang X; Ponta O; Stanzel S; Freyberger A; Kopp-Schneider A
    Toxicol Lett; 2012 Sep; 213(2):292-8. PubMed ID: 22828011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Meta-analysis of the Italian studies on short-term effects of air pollution].
    Biggeri A; Bellini P; Terracini B;
    Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixture models for continuous data in dose-response studies when some animals are unaffected by treatment.
    Boos DD; Brownie C
    Biometrics; 1991 Dec; 47(4):1489-504. PubMed ID: 1786327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Summarizing EC50 estimates from multiple dose-response experiments: a comparison of a meta-analysis strategy to a mixed-effects model approach.
    Jiang X; Kopp-Schneider A
    Biom J; 2014 May; 56(3):493-512. PubMed ID: 24478144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining the error of dose estimates and minimum and maximum acceptable concentrations from assays with nonlinear dose-response curves.
    Gottschalk PG; Dunn JR
    Comput Methods Programs Biomed; 2005 Dec; 80(3):204-15. PubMed ID: 16256244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational tools for fitting the Hill equation to dose-response curves.
    Gadagkar SR; Call GB
    J Pharmacol Toxicol Methods; 2015; 71():68-76. PubMed ID: 25157754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations.
    Mehrotra N; Tang L; Phelps SJ; Meibohm B
    Pharmacotherapy; 2012 May; 32(5):408-19. PubMed ID: 22488303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of methods to handle skew distributed cost variables in the analysis of the resource consumption in schizophrenia treatment.
    Kilian R; Matschinger H; Löeffler W; Roick C; Angermeyer MC
    J Ment Health Policy Econ; 2002 Mar; 5(1):21-31. PubMed ID: 12529567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probabilistic dose-response modeling: case study using dichloromethane PBPK model results.
    Marino DJ; Starr TB
    Regul Toxicol Pharmacol; 2007 Dec; 49(3):285-300. PubMed ID: 17949874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporating additional biological phenomena into two-stage cancer models.
    Sielken RL; Bretzlaff RS; Stevenson DE
    Prog Clin Biol Res; 1994; 387():237-60. PubMed ID: 7972250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Planning a dose-response study with subject-specific doses.
    Gönen M
    Stat Med; 2005 Sep; 24(17):2613-23. PubMed ID: 15977297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Bayesian approach to a logistic regression model with incomplete information.
    Choi T; Schervish MJ; Schmitt KA; Small MJ
    Biometrics; 2008 Jun; 64(2):424-30. PubMed ID: 17764482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling motor vehicle crashes using Poisson-gamma models: examining the effects of low sample mean values and small sample size on the estimation of the fixed dispersion parameter.
    Lord D
    Accid Anal Prev; 2006 Jul; 38(4):751-66. PubMed ID: 16545328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The back-step method--method for obtaining unbiased population parameter estimates for ordered categorical data.
    Kjellsson MC; Jönsson S; Karlsson MO
    AAPS J; 2004 Aug; 6(3):e19. PubMed ID: 15760104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parameters of a dose-response model are on the boundary: what happens with BMDL?
    Kopylev L; Fox J
    Risk Anal; 2009 Jan; 29(1):18-25. PubMed ID: 18808395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new approach to evaluate regression models during validation of bioanalytical assays.
    Singtoroj T; Tarning J; Annerberg A; Ashton M; Bergqvist Y; White NJ; Lindegardh N; Day NP
    J Pharm Biomed Anal; 2006 Apr; 41(1):219-27. PubMed ID: 16332425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of missing data in a generalized integer-valued autoregression model for count data.
    Alosh M
    J Biopharm Stat; 2009 Nov; 19(6):1039-54. PubMed ID: 20183463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for (anti)androgenic properties using a standard operation protocol based on the human stably transfected androgen sensitive PALM cell line. First steps towards validation.
    Freyberger A; Witters H; Weimer M; Lofink W; Berckmans P; Ahr HJ
    Reprod Toxicol; 2010 Aug; 30(1):9-17. PubMed ID: 19836445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of multiple regression to two latent variable techniques for estimation and prediction.
    Wall MM; Li R
    Stat Med; 2003 Dec; 22(23):3671-85. PubMed ID: 14652868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for positive allosteric modulators: assessment of modulator concentration-response curves as a screening paradigm.
    Langmead CJ
    J Biomol Screen; 2007 Aug; 12(5):668-76. PubMed ID: 17478477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.